Table 4. Clinical EAE in adoptive transfer model treated with α-NETA^a.

Treatment group	Mean day of onset (SEM)b	Incidence by day 24 post-immunization
vehicle	13.0 (1.6)	9/13 (69%)
α-NETA	19.0 (2.0)*	6/13 (46%)

^aData are pooled from three independent experiments with each experiment consisting of 3–5 mice per group.

*p<0.05, as determined by Mann-Whitney U test.

^bDetermined only for animals that developed EAE.